The Southern California Regional Gamma Knife Center (Tables)

3 Months Ended

Mar. 31, 2021

Neuro Partners LLC and CGK [Member]

Schedule of Equity Method Investments [Line Items]

Equity Method Investment Summarized Financial Information

The following tables present the aggregation of summarized financial information of NeuroPartners LLC and CGK:

NeuroPartners LLC and CGK Condensed Combined Income Statement Information

	Three Months Ended March 31,
	2021			2020
Patient Revenue	$	166,000		$	316,000
Net income	$	19,000		$	156,000
USNC's equity in (loss) earnings of NeuroPartners LLC and CGK	$	(2,000	)	$	53,000

NeuroPartners LLC and CGK Condensed Combined Balance Sheet Information

		March 31, 2021		December 31, 2020
Current assets	$	140,000	$	121,000
Noncurrent assets		487,000		551,000
Total assets	$	627,000	$	672,000
Current liabilities	$	570,000	$	634,000
Equity		57,000		38,000
Total liabilities and equity	$	627,000	$	672,000